These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16250122)

  • 1. [Usefulness of PET in clinical trials of psychotropic drugs].
    Suhara T; Morimoto T
    Seishin Shinkeigaku Zasshi; 2005; 107(7):704-11. PubMed ID: 16250122
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular imaging for pharmacodynamics of psychotropic drugs].
    Suhara T
    Seishin Shinkeigaku Zasshi; 2007; 109(9):869-75. PubMed ID: 18213899
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.
    Talbot PS; Laruelle M
    Eur Neuropsychopharmacol; 2002 Dec; 12(6):503-11. PubMed ID: 12468013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of drug therapy based on the results of imaging].
    Suhara T
    Seishin Shinkeigaku Zasshi; 2004; 106(7):916-20. PubMed ID: 15478634
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacogenetic studies on psychotropic agents].
    Otani K
    Seishin Shinkeigaku Zasshi; 2002; 104(1):71-5. PubMed ID: 11928315
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders.
    Hesse S; Barthel H; Schwarz J; Sabri O; Müller U
    Neurosci Biobehav Rev; 2004 Oct; 28(6):547-63. PubMed ID: 15527862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vivo evaluation of expressed protein function by PET].
    Matsumoto R; Suhara T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):137-41. PubMed ID: 16045196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT.
    van der Wee NJ; Stevens H; Hardeman JA; Mandl RC; Denys DA; van Megen HJ; Kahn RS; Westenberg HM
    Am J Psychiatry; 2004 Dec; 161(12):2201-6. PubMed ID: 15569890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of imaging biomarkers in exploratory clinical trials].
    Takano H; Suhara T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):55-9. PubMed ID: 19562942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
    Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y
    Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease.
    Paus S; Seeger G; Brecht HM; Köster J; El-Faddagh M; Nöthen MM; Klockgether T; Wüllner U
    Mov Disord; 2004 Jun; 19(6):705-7. PubMed ID: 15197713
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
    J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
    Lundberg J; Odano I; Olsson H; Halldin C; Farde L
    J Nucl Med; 2005 Sep; 46(9):1505-15. PubMed ID: 16157534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular imaging in the drug development of psychotropics using positron emission tomography].
    Takano H; Takahashi H; Ito H; Suhara T
    Brain Nerve; 2007 Mar; 59(3):215-20. PubMed ID: 17370647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.
    Talbot PS; Frankle WG; Hwang DR; Huang Y; Suckow RF; Slifstein M; Abi-Dargham A; Laruelle M
    Synapse; 2005 Mar; 55(3):164-75. PubMed ID: 15605360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging neurochemical endophenotypes: promises and pitfalls.
    Martinez D; Broft A; Laruelle M
    Pharmacogenomics; 2001 Aug; 2(3):223-37. PubMed ID: 11535111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.
    Cai Z; Li S; Matuskey D; Nabulsi N; Huang Y
    Neurosci Lett; 2019 Jan; 691():44-50. PubMed ID: 30075287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo snapshots of the dopaminergic synapse in small animals.
    Nikolaus S; Beu M; Wirrwar A; Antke C; Müller HW
    Mol Psychiatry; 2005 Jun; 10(6):516-8. PubMed ID: 15920466
    [No Abstract]   [Full Text] [Related]  

  • 20. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
    Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
    Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.